40
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Social challenges, autism spectrum disorder, and attention deficit/hyperactivity disorder in youth with neurofibromatosis type I

ORCID Icon, , , , , & show all

References

  • Achenbach, T. M., & Rescorla, L. A. (2001). Manual for the ASEBA School-Age Forms & Profiles. University of Vermont, Research Center for Children, Youth, & Families.
  • Adviento, B., Corbin, I. L., Widjaja, F., Desachy, G., Enrique, N., Rosser, T., Risi, S., Marco, E. J., Hendren, R. L., Bearden, C. E., Rauen, K. A., & Weiss, L. A. (2014). Autism traits in the RASopathies. Journal of Medical Genetics, 51(1), 10–20. https://doi.org/10.1136/jmedgenet-2013-101951
  • Barton, B., & North, K. (2004). Social skills of children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 46(08), 553–563. https://doi.org/10.1017/S0012162204000921
  • Behrens, B., Swetlitz, C., Pine, D. S., & Pagliaccio, D. (2019). The screen for child anxiety related emotional disorders (SCARED): Informant discrepancy, measurement invariance, and test-retest reliability. Child Psychiatry and Human Development, 50(3), 473–482. https://doi.org/10.1007/s10578-018-0854-0
  • Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999). Autism screening questionnaire: Diagnostic validity. British Journal of Psychiatry, 175(5), 444–451. https://doi.org/10.1192/bjp.175.5.444
  • Bishop, S. L., Huerta, M., Gotham, K., Alexandra Havdahl, K., Pickles, A., Duncan, A., Hus Bal, V., Croen, L., & Lord, C. (2017). The autism symptom interview, school age: A brief telephone interview to identify autism spectrum disorders in 5-to-12-year-old children. Autism Research: official Journal of the International Society for Autism Research, 10(1), 78–88. https://doi.org/10.1002/aur.1645
  • Bölte, S., Westerwald, E., Holtmann, M., Freitag, C., & Poustka, F. (2011). Autistic traits and autism spectrum disorders: The clinical validity of two measures presuming a continuum of social communication skills. Journal of Autism and Developmental Disorders, 41(1), 66–72. https://doi.org/10.1007/s10803-010-1024-9
  • Chen, W. J., Faraone, S. V., Biederman, J., & Tsuang, M. T. (1994). Diagnostic accuracy of the Child Behavior Checklist scales for attention-deficit hyperactivity disorder: A receiver-operating characteristic analysis. Journal of Consulting and Clinical Psychology, 62(5), 1017–1025. https://doi.org/10.1037/0022-006X.62.5.1017
  • Chisholm, A. K., Anderson, V. A., Pride, N. A., Malarbi, S., North, K. N., & Payne, J. M. (2018). Social function and autism spectrum disorder in children and adults with neurofibromatosis type 1: A systematic review and meta-analysis. Neuropsychology Review, 28(3), 317–340. https://doi.org/10.1007/s11065-018-9380-x
  • Chisholm, A. K., Haebich, K. M., Pride, N. A., Walsh, K. S., Lami, F., Ure, A., Maloof, T., Brignell, A., Rouel, M., Granader, Y., Maier, A., Barton, B., Darke, H., Dabscheck, G., Anderson, V. A., Williams, K., North, K. N., & Payne, J. M. (2022). Delineating the autistic phenotype in children with neurofibromatosis type 1. Molecular Autism, 13(1), 3. https://doi.org/10.1186/s13229-021-00481-3
  • Constantino, J. N., & Gruber, C. P. (2012). (SRSTM -2) Social Responsiveness ScaleTM. Second Edition. Western Psychological Services.
  • Daston, M. M., & Ratner, N. (1992). Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Developmental Dynamics: An Official Publication of the American Association of Anatomists, 195(3), 216–226. https://doi.org/10.1002/aja.1001950307
  • Dilts, C. V., Carey, J. C., Kircher, J. C., Hoffman, R. O., Creel, D., Ward, K., Clark, E., & Leonard, C. O. (1996). Children and adolescents with neurofibromatosis type 1: A behavioral phenotype. Journal of Developmental & Behavioral Pediatrics, 17(4), 229–239. https://doi.org/10.1097/00004703-199608000-00004
  • Dow, D., Holbrook, A., Toolan, C., McDonald, N., Sterrett, K., Rosen, N., Hyun Kim, S., & Lord, C. (2022). The brief observation of symptoms of autism (BOSA): Development of a new adapted assessment measure for remote telehealth administration through COVID-19 and Beyond. Journal of Autism and Developmental Disorders, 52(12), 5383–5394. https://doi.org/10.1007/s10803-021-05395-w
  • DuPaul, G. J., Power, T. J., Anastopoulos, A. D., & Reid, R. (2016). ADHD Rating Scale - 5 for Children and Adolescents: Checklists, Norms, and Clinical Intepretation. Guilford Press.
  • Eijk, S., Mous, S. E., Dieleman, G. C., Dierckx, B., Rietman, A. B., de Nijs, P. F. A., Ten Hoopen, L. W., van Minkelen, R., Elgersma, Y., Catsman-Berrevoets, C. E., Oostenbrink, R., & Legerstee, J. S. (2018). Autism spectrum disorder in an unselected cohort of children with neurofibromatosis Type 1 (NF1). Journal of Autism and Developmental Disorders, 48(7), 2278–2285. https://doi.org/10.1007/s10803-018-3478-0
  • Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, D. G., & Huson, S. M. (2013). Neurofibromatosis Type 1 and autism spectrum disorder. Pediatrics, 132(6), e1642-1648–e1648. https://doi.org/10.1542/peds.2013-1868
  • Gibbs, V., Aldridge, F., Chandler, F., Witzlsperger, E., & Smith, K. (2012). Brief report: An exploratory study comparing diagnostic outcomes for autism spectrum disorders under DSM-IV-TR with the proposed DSM-5 revision. Journal of Autism and Developmental Disorders, 42(8), 1750–1756. https://doi.org/10.1007/s10803-012-1560-6
  • Glad, D. M., Casnar, C. L., Yund, B. D., Lee, K., & Klein-Tasman, B. P. (2021). Parent-reported social skills in children with neurofibromatosis type 1: Longitudinal patterns and relations with attention and cognitive functioning. Journal of Developmental & Behavioral Pediatrics, 42(8), 656–665. https://doi.org/10.1097/DBP.0000000000000939
  • Haebich, K. M., Dao, D. P., Pride, N. A., Barton, B., Walsh, K. S., Maier, A., Chisholm, A. K., Darke, H., Catroppa, C., Malarbi, S., Wilkinson, J. C., Anderson, V. A., North, K. N., & Payne, J. M. (2022). The mediating role of ADHD symptoms between executive function and social skills in children with neurofibromatosis type 1. Child Neuropsychology: a Journal on Normal and Abnormal Development in Childhood and Adolescence, 28(3), 318–336. https://doi.org/10.1080/09297049.2021.1976129
  • Haebich, K. M., Pride, N. A., Collins, A., Porter, M. A., Anderson, V., Maier, A., Darke, H., North, K. N., & Payne, J. M. (2023). Understanding nonliteral language abilities in children with neurofibromatosis type 1. Neuropsychology, 37(8), 872–882. https://doi.org/10.1037/neu0000916
  • Harstad, E., Hanson, E., Brewster, S. J., DePillis, R., Milliken, A. L., Aberbach, G., Sideridis, G., & Barbaresi, W. J. (2023). Persistence of autism spectrum disorder from early childhood through school age. JAMA Pediatrics, 177(11), e234003–1205. https://doi.org/10.1001/jamapediatrics.2023.4003
  • Humphreys, K. L., Galán, C. A., Tottenham, N., & Lee, S. S. (2016). Impaired social decision-making mediates the association between ADHD and social problems. Journal of Abnormal Child Psychology, 44(5), 1023–1032. https://doi.org/10.1007/s10802-015-0095-7
  • Hyman, S. L., Shores, A., & North, K. N. (2005). The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology, 65(7), 1037–1044. https://doi.org/10.1212/01.wnl.0000179303.72345.ce
  • Johnson, N. S., Saal, H. M., Lovell, A. M., & Schorry, E. K. (1999). Social and emotional problems in children with neurofibromatosis type 1: Evidence and proposed interventions. The Journal of Pediatrics, 134(6), 767–772. https://doi.org/10.1016/s0022-3476(99)70296-9
  • Kenworthy, L., Anthony, L. G., Naiman, D. Q., Cannon, L., Wills, M. C., Luong-Tran, C., Werner, M. A., Alexander, K. C., Strang, J., Bal, E., Sokoloff, J. L., & Wallace, G. L. (2014). Randomized controlled effectiveness trial of executive function intervention for children on the autism spectrum. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 55(4), 374–383. https://doi.org/10.1111/jcpp.12161
  • Klein-Tasman, B. P., Janke, K. M., Luo, W., Casnar, C. L., Hunter, S. J., Tonsgard, J., Trapane, P., van der Fluit, F., & Kais, L. A. (2014). Cognitive and psychosocial phenotype of young children with neurofibromatosis-1. Journal of International Neuropsychological Society, 20, 88–98.
  • Kofler, M. J., Harmon, S. L., Aduen, P. A., Day, T. N., Austin, K. E., Spiegel, J. A., Irwin, L., & Sarver, D. E. (2018). Neurocognitive and behavioral predictors of social problems in ADHD: A Bayesian framework. Neuropsychology, 32(3), 344–355. https://doi.org/10.1037/neu0000416
  • Kofler, M. J., Rapport, M. D., Bolden, J., Sarver, D. E., Raiker, J. S., & Alderson, R. M. (2011). Working memory deficits and social problems in children with ADHD. Journal of Abnormal Child Psychology, 39(6), 805–817. https://doi.org/10.1007/s10802-011-9492-8
  • Kovacs, M. (2003). Children’s Depression Inventory. Multi-Health Systems Inc.
  • Ladd, G. W., & Troop-Gordon, W. (2003). The role of chronic peer difficulties in the development of children’s psychological adjustment problems. Child Development, 74(5), 1344–1367. https://doi.org/10.1111/1467-8624.00611
  • Lainhart, J. E., Bigler, E. D., Bocian, M., Coon, H., Dinh, E., Dawson, G., Deutsch, C. K., Dunn, M., Estes, A. M., Tager-Flusberg, H., Folstein, S., Hepburn, S., Hyman, S., McMahon, W. M., Minshew, M., Munson, J., Osann, K., Ozonoff, S., Rodier, P., … Volkmar, F. (2006). Head circumference and height in autism: a study by the collaborative program of excellence in Autism. American Journal of Medical Genetics, Part A, 140(21), 2257–2274.
  • Lansford, J. E., Dodge, K. A., Fontaine, R. G., Bates, J. E., & Pettit, G. S. (2014). Peer rejection, affiliation with deviant peers, delinquency, and risky sexual behavior. Journal of Youth and Adolescence, 43(10), 1742–1751. https://doi.org/10.1007/s10964-014-0175-y
  • Levitt, P., & Campbell, D. B. (2009). The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. The Journal of Clinical Investigation, 119(4), 747–754. https://doi.org/10.1172/JCI37934
  • Lord, C., Holbrook, A., Dow, D., Byrne, K., Grzadzinksi, R., Sterrett, K., Toolan, C., & Kim, S. H. (2020). Brief observation of symptoms of autism Western Psychological Services.
  • Lord, C., Petkova, E., Hus, V., Gan, W., Lu, F., Martin, D. M., Ousley, O., Guy, L., Bernier, R., Gerdts, J., Algermissen, M., Whitaker, A., Sutcliffe, J. S., Warren, Z., Klin, A., Saulnier, C., Hanson, E., Hundley, R., Piggot, J., … Risi, S. (2012). A multisite study of the clinical diagnosis of different autism spectrum disorders. Archives of General Psychiatry, 69(3), 306–313. https://doi.org/10.1001/archgenpsychiatry.2011.148
  • Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Leventhal, B. L., DiLavore, P. C., Pickles, A., & Rutter, M. (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30(3), 205–223.
  • Lubbers, K., Stijl, E. M., Dierckx, B., Hagenaar, D. A., Ten Hoopen, L. W., Legerstee, J. S., de Nijs, P. F. A., Rietman, A. B., Greaves-Lord, K., Hillegers, M. H. J., Dieleman, G. C., & Mous, S. E,. (2022). Autism symptoms in children and young adults with fragile X syndrome, Angelman syndrome, tuberous sclerosis complex, and neurofibromatosis type 1: A cross-syndrome comparison. Frontiers in Psychiatry, 13, 852208. https://doi.org/10.3389/fpsyt.2022.852208
  • Mautner, V. F., Kluwe, L., Thakker, S. D., & Leark, R. A. (2002). Treatment of ADHD in neurofibromatosis type 1. Developmental Medicine & Child Neurology, 44(3), 164–170. https://doi.org/10.1111/j.1469-8749.2002.tb00780.x
  • Morris, S. M., Acosta, M. T., Garg, S., Green, J., Huson, S., Legius, E., North, K. N., Payne, J. M., Plasschaert, E., Frazier, T. W., Weiss, L. A., Zhang, Y., Gutmann, D. H., & Constantino, J. N. (2016). Disease burden and symptom structure of autism in neurofibromatosis type 1: A study of the international NF1-ASD consortium team (INFACT). JAMA Psychiatry, 73(12), 1276–1284. https://doi.org/10.1001/jamapsychiatry.2016.2600
  • Noll, R. B., Reiter-Purtill, J., Moore, B. D., Schorry, E. K., Lovell, A. M., Vannatta, K., & Gerhardt, C. A. (2007). Social, emotional, and behavioral functioning of children with NF1. American Journal of Medical Genetics. Part A, 143A(19), 2261–2273. https://doi.org/10.1002/ajmg.a.31923
  • North, K., Joy, P., Yuille, D., Cocks, N., & Hutchins, P. (1995). Cognitive function and academic performance in children with neurofibromatosis type 1. Developmental Medicine and Child Neurology, 37(5), 427–436. https://doi.org/10.1111/j.1469-8749.1995.tb12026.x
  • Payne, J. M., Haebich, K. M., MacKenzie, R., Walsh, K. S., Hearps, S. J. C., Coghill, D., Barton, B., Pride, N. A., Ullrich, N. J., Tonsgard, J., Viskochil, D., Schorry, E. K., Klesse, L., Fisher, M. J., Gutmann, D. H., Rosser, T., Packer, R. J., Korf, B., Acosta, M. T., Bellgrove, M. A., & North, K. N. (2021). Cognition, ADHD symptoms, and functional impairment in children and adolescents with neurofibromatosis type 1. Journal of Attention Disorders, 25(8), 1177–1186. https://doi.org/10.1177/1087054719894384
  • Plasschaert, E., Descheemaeker, M.-J., Van Eylen, L., Noens, I., Steyaert, J., & Legius, E. (2016). Prevalence of autism spectrum disorder symptoms in children with Neurofbromatosis Type 1. American Journal of Medical Genetics Part B, 168B, 72–80.
  • Prinstein, M. J., & Aikins, J. W. (2004). Cognitive mediators of the longitudinal association between peer rejection and adolescent depressive symptoms. Journal of Abnormal Child Psychology, 32(2), 147–158. https://doi.org/10.1023/b:jacp.0000019767.55592.63
  • Prinstein, M. J., Boergers, J., Spirito, A., Little, T. D., & Grapentine, W. L. (2000). Peer functioning, family dysfunction, and psychological symptoms in a risk factor model for adolescent inpatients’ suicidal ideation severity. Journal of Clinical Child Psychology, 29(3), 392–405. https://doi.org/10.1207/S15374424JCCP2903_10
  • Psychopharmacology, O. R. U. o. P. (2005). The OSU Research Unit on Pediatric Psychopharmacology: OSU Autism Rating Scale - DSM-IV (OARS-4).
  • Reiersen, A. M., Constantino, J. N., Volk, H. E., & Todd, R. D. (2007). Autistic traits in a population-based ADHD twin sample. Journal of Child Psychology and Psychiatry, 48(5), 464–472. https://doi.org/10.1111/j.1469-7610.2006.01720.x
  • Reynolds, C. R., & Kamphaus, R. W. (2006). BASC-2: Behavior Assessment System for Children, Second Edition. Pearson Education, Inc.
  • Rutter, M., Bailey, A., & Lord, C. (2003). Social Communication Questionnaire (SCQ). Western Psychological Services.
  • Torres Nupan, M. M., Velez Van Meerbeke, A., Cabra, C. A. L., & Herrera Gomez, P. M. (2017). Cognitive and behavioral disorders in children with neurofibromatosis type 1. Frontiers in Pediatrics, 5, 227. https://doi.org/10.3389/fped.2017.00227
  • Walsh, K. S., Vélez, J. I., Kardel, P. G., Imas, D. M., Muenke, M., Packer, R. J., Castellanos, F. X., & Acosta, M. T. (2013). Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 55(2), 131–138. https://doi.org/10.1111/dmcn.12038
  • Wechsler, D. (2014). Wechsler Intelligence Scale for Children - Fifth Edition (WISC-V). Pearson.
  • Wilson, C. E., Gillan, N., Spain, D., Robertson, D., Roberts, G., Murphy, C. M., Maltezos, S., Zinkstok, J., Johnston, K., Dardani, C., Ohlsen, C., Deeley, P. Q., Craig, M., Mendez, M. A., Happé, F., & Murphy, D. G. M. (2013). Comparison of ICD-10R, DSM-IV-TR and DSM-5 in an adult autism spectrum disorder diagnostic clinic. Journal of Autism and Developmental Disorders, 43(11), 2515–2525. https://doi.org/10.1007/s10803-013-1799-6
  • Yerys, B. E., Bertollo, J. R., Pandey, J., Guy, L., & Schultz, R. T. (2019). Attention-deficit/hyperactivity disorder symptoms are associated with lower adaptive behavior skills in children with autism. Journal of American Academy of Child and Adolescent Psychiatry, 58, 525–533.
  • Young, R. L., & Rodi, M. L. (2014). Redefining autism spectrum disorder using DSM-5: The implications of the proposed DSM-5 criteria for autism spectrum disorders. Journal of Autism and Developmental Disorders, 44(4), 758–765. https://doi.org/10.1007/s10803-013-1927-3
  • Zhu, Y., Harada, T., Liu, L., Lush, M. E., Guignard, F., Harada, C., Burns, D. K., Bajenaru, M. L., Gutmann, D. H., & Parada, L. F. (2005). Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation. Development, 132(24), 5577–5588. https://doi.org/10.1242/dev.02162

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.